MedPath

Evaluation of EMI in Patients With Micra Leadless Pacemaker

Completed
Conditions
Electromagnetic Interference
Registration Number
NCT03508128
Lead Sponsor
Edward-Elmhurst Health System
Brief Summary

Subjects with Medtronic Micra leadless pacemaker who require surgical procedures will have postoperative interrogations reviewed for evidence of electromagnetic interference (EMI).

Detailed Description

Patients with pacemakers have a potential risk of EMI from sources including electrosurgery which can cause oversensing, pacing inhibition and device reset. There is limited data on surgical EMI in Medtronic Micra leadless pacemakers. The goal of this study is to evaluate for surgical EMI in subjects with leadless pacemakers.

Subjects with Micra leadless pacemakers requiring surgery will have procedure records reviewed for type of procedure and use of electrosurgery. Next postoperative device interrogation will be reviewed for evidence of EMI. EMI will be evaluated by review of sensing integrity counter, heart rate histograms and device reset.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria

Not provided

Exclusion Criteria
  • no Micra pacemaker

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EMIup to 6 months next postop interrogation

Number of subjects with evidence of EMI determined by sensing integrity counter and heart rate histograms

Secondary Outcome Measures
NameTimeMethod
Device resetup to 6 months next postop interrogation

Number of subjects with change in programmed parameters showing device reset VVI 65 5V@.4ms

Trial Locations

Locations (1)

EdwardElmhurst Healthcare

πŸ‡ΊπŸ‡Έ

Naperville, Illinois, United States

EdwardElmhurst Healthcare
πŸ‡ΊπŸ‡ΈNaperville, Illinois, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.